Mounjaro costs between $1,000 and $1,200 per month without insurance, making it one of the most expensive prescriptions many people will ever fill. But several strategies can bring that price down dramatically, sometimes to as little as $25 per month. The right approach depends on whether you have insurance, what condition you’re treating, and how much legwork you’re willing to do.
Use the Manufacturer’s Savings Card
Eli Lilly, the company behind Mounjaro, offers a savings card that can cut your cost to $25 for up to a three-month supply if you have commercial insurance that covers the drug. The card provides up to $150 in savings per one-month fill, $300 for two months, or $450 for three months, with a separate annual cap of $1,950 in total savings per calendar year.
If your commercial insurance doesn’t cover Mounjaro, the savings card still helps but less generously. In that case, you can get up to $469 off each monthly fill, with an annual cap of $3,283. That still leaves you paying roughly $550 to $730 per month out of pocket, which is better than full price but far from cheap.
The savings card is not available to anyone on a government plan: Medicare, Medicaid, Medicare Part D, Medicare Advantage, TRICARE, VA benefits, or any state prescription assistance program. You must be 18 or older and a U.S. resident.
Get Your Insurance to Cover It
Most insurance plans require prior authorization before they’ll pay for Mounjaro. That means your doctor submits paperwork proving you meet specific clinical criteria. Knowing what insurers look for can help you and your doctor build a stronger case.
For a type 2 diabetes indication, plans typically require documented evidence of the diagnosis (usually an A1C of 6.5% or higher), proof that you’re 18 or older, and evidence that you tried metformin first for at least three months at an adequate dose. If metformin didn’t work well enough or you can’t tolerate it, the insurer then often requires that you also tried and failed other, cheaper injectable medications in the same drug class before they’ll approve Mounjaro. This “step therapy” process can take months, but completing it is often the fastest route to affordable coverage.
If your prior authorization is denied, appeal it. Many initial denials get overturned on appeal, especially when your doctor includes detailed clinical notes explaining why alternatives weren’t effective. Ask your doctor’s office to handle the appeal paperwork, since they do this regularly.
Consider Zepbound Instead
Zepbound is the exact same molecule as Mounjaro (tirzepatide), made by the same company, but approved specifically for weight loss and obstructive sleep apnea rather than type 2 diabetes. If you’re using tirzepatide primarily for weight management and don’t have a diabetes diagnosis, Zepbound may actually be easier to get covered because your insurer won’t question why a “diabetes drug” is being prescribed for weight loss.
Zepbound has its own savings card with the same basic structure: as low as $25 per month with commercial insurance that covers it, or up to $469 off per fill if your plan doesn’t cover it. The same government-plan exclusions apply. Since the two drugs are identical in formulation, switching between them based on which one your insurance prefers is a legitimate conversation to have with your prescriber.
Compare Pharmacy Prices
Even at full retail, prices vary by pharmacy. The list price is roughly $1,080 for a box of four prefilled pens (one month’s supply), but some pharmacies charge over $1,200. Tools like GoodRx, RxSaver, and Cost Plus Drugs let you compare prices at pharmacies near you and sometimes offer discount codes that shave off a percentage. The savings from pharmacy shopping alone won’t transform your bill, but combining a coupon with the manufacturer savings card can chip away at the total.
Mail-order pharmacies and specialty pharmacies affiliated with your insurance plan sometimes offer lower negotiated rates than retail chains. Check whether your plan has a preferred pharmacy for specialty medications.
What About Compounded Tirzepatide?
Compounded versions of tirzepatide gained popularity during drug shortages, when compounding pharmacies could legally produce copies of medications in short supply. Prices for compounded tirzepatide have been significantly cheaper, often $200 to $500 per month depending on the dose and pharmacy.
However, the landscape has shifted. Tirzepatide no longer appears on the FDA’s drug shortage list, which changes the legal basis for compounding it. Under federal law, compounding pharmacies generally cannot produce drugs that are “essentially a copy” of a commercially available product unless that product is on the shortage list. The FDA has signaled it may take enforcement action against compounders who continue producing tirzepatide now that supply has stabilized.
There’s also a quality concern. Compounded drugs do not go through the FDA’s approval process for safety, effectiveness, or manufacturing quality. The FDA has explicitly warned that compounded versions may be of substandard quality or otherwise unsafe. Some compounded products have been found to contain incorrect doses or impurities. If you’re currently using compounded tirzepatide, it’s worth understanding that this option may become harder to find and carries risks that the brand-name version does not.
Other Ways to Lower Your Cost
Patient assistance programs run by Eli Lilly may help if you’re uninsured or underinsured and meet income requirements. The Lilly Cares program provides free medications to qualifying patients. Eligibility typically depends on household income and lack of prescription coverage. Your doctor’s office can help you apply.
Some employers are adding GLP-1 medications to their formularies as they recognize the long-term cost savings of treating obesity and diabetes. If your employer’s plan doesn’t currently cover Mounjaro or Zepbound, it’s worth asking your HR department whether coverage changes are planned. Employer plans update their formularies annually, and employee requests can influence those decisions.
Dose optimization is another practical lever. Mounjaro is prescribed at increasing doses over time, and each dose tier costs the same amount per box. Starting at the lowest effective dose and only increasing when medically necessary keeps you at the cheapest tier for as long as possible, since lower doses stretch further if your doctor determines a slower titration is appropriate for you.
Finally, flexible spending accounts (FSAs) and health savings accounts (HSAs) let you pay for Mounjaro with pre-tax dollars. This doesn’t change the sticker price, but it effectively gives you a discount equal to your marginal tax rate, which for many people means 22% to 32% off.